InvestorsHub Logo
Followers 19
Posts 532
Boards Moderated 0
Alias Born 07/13/2022

Re: biotechinvestor1 post# 8873

Tuesday, 08/06/2024 11:38:58 AM

Tuesday, August 06, 2024 11:38:58 AM

Post# of 9387
Agree. I have a buy limit order pending if the price drops a bit more.

Meanwhile, the cover story of this week's Barron's is about Merck. There is a very interesting passage, several paragraphs, about Merck's strategy with respect to developing a subcutaneous version of its blockbuster cancer drug Keytruda (pembrolizumab).

Is anyone interested in this? If so, I will be happy to share. If it's old news, I won't bother.

-- OJ
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News